FDA Approves First Powered Exoskeleton

DAN HURLEY

首页> 外文期刊>Discover >FDA Approves First Powered Exoskeleton

【24h】

FDA Approves First Powered Exoskeleton

机译：FDA批准首款动力外骨骼

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

A powered exoskeleton, long an object of fascination for science fiction writers and researchers alike, won federal approval last summer. Now paraplegics can use the device to sit, stand and walk. The Re Walk first made headlines in 2012 when the device, then experimental, helped a woman with paraplegia complete the London Marathon. On June 26, the FDA gave the go-ahead to market it directly to consumers, and two weeks later, a retired U.S. Army sergeant became the first patient in the U.S. to take one home. A Veterans Affairs official said the agency would pay the $69,500 price tag, but it's unclear whether private insurers or Medicare will cover the device.

机译：动力十足的外骨骼，长期以来一直是科幻小说家和研究人员着迷的对象，去年夏天获得了联邦的批准。现在，截瘫患者可以使用该设备坐下，站立和行走。 Re Walk首先在2012年成为头条新闻，当时该设备随后进行了实验，帮助一名截瘫的妇女完成了伦敦马拉松比赛。 6月26日，FDA批准将其直接销售给消费者，两周后，一名退休的美国陆军中士成为美国第一位带回家的患者。退伍军人事务部的一位官员说，该机构将支付69,500美元的价格，但目前尚不清楚私人保险公司或Medicare是否将承保该设备。

著录项

来源
《Discover》 |2015年第1期|60-60|共1页
作者
DAN HURLEY;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Supplemental Actions Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2011,第9期

机译：当前与FDA有关的药物信息由FDA批准的新药物新剂型和适应症，由FDA代理商批准的待批FDA批准的新药/生物许可申请，由制造商提出的补充措施，由制造商提出的重要措施，或与“亲爱的健康专业人员”的信件有关安全
2. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval Supplemental Applications Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2011,第6期

机译：当前与FDA有关的药物信息由FDA批准的新药，由FDA代理商批准的新剂型和适应症，待FDA批准的制造商提出的补充申请重大的标签变更或“与安全有关的亲爱的健康专业人士”
3. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2011,第4期

机译：FDA批准的最新FDA相关药物信息新药FDA批准的新剂型和适应症FDA批准的FDA批准的重要标签变更或与安全相关的“亲爱的健康专业人员”字母
4. Using Machine Learning to Predict the Binding Dissociation of FDA Approved Drugs for Affinity- Based Drug Delivery Applications [C] . Edgardo Rivera-Delgado, Alison Xin, Horst A. von Recum Society for Biomaterials annual meeting and exposition . 2019

机译：使用机器学习预测基于亲和力的药物递送应用的FDA批准药物的结合解离
5. Molecular Determinants for Binding of the FDA-Approved Drugs in Proteins – A Data Mining and Advanced Quantum Chemical Study [D] . Alqahtani, Saad. 2017

机译：FDA批准的药物与蛋白质结合的分子决定因素–数据挖掘和先进的量子化学研究
6. The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment [O] . Christine M. Gunn, Michael K. Paasche-Orlow 2019

机译：FDA批准的安抚设备咨询命令未能促进患者授权
7. The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment [O] . Christine M. Gunn, Michael K. Paasche-Orlow 2019

机译：FDA批准的本发明咨询订单未能促进患者赋权

FDA Approves First Powered Exoskeleton

摘要

著录项

相似文献

相关主题

期刊订阅